What does the usual drug benefit cover?
Part D is the name of Medicare’s prescription-drug benefit. The use of the medicine matters.
In ordinary Part D, medicines used for weight loss remain excluded from coverage as of September 2026.
As of September 2026, another accepted condition may make a medicine coverable, subject to the plan’s rules for approval and its covered-medicine list.
Coverable means it can qualify. That alone gives no assurance that your plan has agreed to payment.
What is the separate Bridge program?
GLP-1 is made by your body and helps regulate blood sugar and hunger. GLP-1 medicines copy its action. Medicare’s temporary GLP-1 Bridge program covers certain weight medicines.
As of September 2026, eligible Bridge participants paid $50 per monthly supply; July 1, 2026 was the program’s start date, and December 31, 2027 its end date.
That program runs separately from ordinary Part D. It is not a general peptide or energy benefit.
Under the September 2026 rules, paying the Bridge’s $50 does not count toward the yearly ceiling for your payments on Part D-covered medicines.
Those September 2026 rules also exclude the Bridge payment from extra low-income help.
Can I assume I qualify?
No. Ask the health professional writing the prescription to check the current rules, the exact product and the reason for treatment.
As of September 2026, Bridge entry required a prescription, approval before payment, and specific age, weight, health and plan conditions.
The September 2026 rules excluded people with type 2 diabetes from the Bridge; that use goes through ordinary Part D coverage instead.
Type 2 diabetes is a condition affecting blood sugar. That exclusion is about the payment route, not a guarantee of ordinary coverage.
Which product details matter?
As checked in September 2026, the Bridge covered the medicines listed below.
- Orforglipron is sold as Foundayo.
- Semaglutide is sold as Wegovy, as tablets or injection.
- Tirzepatide is sold as Zepbound; the Bridge covers it only in KwikPen, a device that holds medicine for a shot.
For the coverage check, bring the exact product name plus its form: a tablet or the particular injection device. A similar name or another device does not settle the answer.
Ask it like this
- Does my prescription use ordinary Part D or the Bridge?
- Does my exact medicine qualify as a tablet or in the injection device prescribed?
- Who sends the approval request?